# Lidocaine Hydrochloride Injection: FDA shortage status > FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice. - Derived status: current - Source statuses: Current, To Be Discontinued - FDA package records: 69 - Latest FDA row update: 11/07/2025 - Retrieved: 2026-08-22T15:54:11+00:00 ## FDA package and manufacturer records - Amphastar Pharmaceuticals, Inc. — Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 76329-3390-1) — FDA availability: Limited Availability — updated: 08/18/2026 - Anthea Pharma — Lidocaine Hydochloride, Injection, 50 mg/5 mL (NDC 83634-653-05) — FDA availability: Available — updated: 08/04/2026 - Anthea Pharma — Lidocaine Hydrochloride, Injection, 100 mg/10 mL (NDC 83634-651-10) — FDA availability: Available — updated: 08/04/2026 - Anthea Pharma — Lidocaine Hydrochloride, Injection, 20 mg/2 mL (NDC 83634-653-02) — FDA availability: Available — updated: 08/04/2026 - Anthea Pharma — Lidocaine Hydrochloride, Injection, 200 mg/20 mL (NDC 83634-651-20) — FDA availability: Available — updated: 08/04/2026 - Anthea Pharma — Lidocaine Hydrochloride, Injection, 300 mg/30 mL (NDC 83634-653-30) — FDA availability: Available — updated: 08/04/2026 - Anthea Pharma — Lidocaine Hydrochloride, Injection, 500 mg/50 mL (NDC 83634-651-50) — FDA availability: Available — updated: 08/04/2026 - B. Braun Medical Inc. — Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-10) — FDA availability: Available — updated: 08/07/2026 - B. Braun Medical Inc. — Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-20) — FDA availability: Available — updated: 08/07/2026 - B. Braun Medical Inc. — Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .8 g/100 mL (NDC 0264-9598-20) — FDA availability: Available — updated: 08/07/2026 - Baxter Healthcare — Lidocaine Hydrochloride And Dextrose, Injection, 4 mg/1 mL (NDC 0338-0409-03) — FDA availability: Available — updated: 08/17/2026 - Baxter Healthcare — Lidocaine Hydrochloride And Dextrose, Injection, 8 mg/1 mL (NDC 0338-0411-02) — FDA availability: Available — updated: 08/17/2026 - Eugia US LLC — Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-159-74) — FDA availability: Unavailable — updated: 08/06/2026 - Eugia US LLC — Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-161-02) — FDA availability: Available — updated: 08/06/2026 - Eugia US LLC — Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-162-05) — FDA availability: Available — updated: 08/06/2026 - Eugia US LLC — Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-163-30) — FDA availability: Available — updated: 08/06/2026 - Eugia US LLC — Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-251-10) — FDA availability: Unavailable — updated: 08/06/2026 - Eugia US LLC — Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-252-20) — FDA availability: Available — updated: 08/06/2026 - Eugia US LLC — Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 55150-165-05) — FDA availability: Available — updated: 08/06/2026 - Eugia US LLC — Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-164-02) — FDA availability: Available — updated: 08/06/2026 - Eugia US LLC — Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-254-10) — FDA availability: Unavailable — updated: 08/06/2026 - Eugia US LLC — Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-255-20) — FDA availability: Unavailable — updated: 08/06/2026 - Eugia US LLC — Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-256-50) — FDA availability: Unavailable — updated: 08/06/2026 - Fresenius Kabi USA, LLC — Lidocaine Hydrochloride In Plastic Container, Injection, 10 mg/1 mL (NDC 63323-201-02) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/1 mL (NDC 63323-208-05) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-201-10) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 63323-202-02) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-27) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-57) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-27) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-31) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-37) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-57) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-91) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-97) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-17) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-27) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-57) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-07) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-27) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Xylocaine, Injection, 20 mg/1 mL (NDC 63323-496-97) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Xylocaine, Injection, 5 mg/1 mL (NDC 63323-484-57) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Xylocaine, Injection, 5 mg/1 mL (NDC 63323-491-57) — FDA availability: Available — updated: 08/04/2026 - Hikma Pharmaceuticals USA, Inc. — Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 0143-9577-10) — FDA availability: Available — updated: 08/13/2026 - Hikma Pharmaceuticals USA, Inc. — Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 0143-9575-10) — FDA availability: Available — updated: 08/13/2026 - Hikma Pharmaceuticals USA, Inc. — Lidocaine Hydrochloride, Preservative Free, Injection, 10 mg/1 mL (NDC 0143-9595-25) — FDA availability: Available — updated: 08/13/2026 - Hikma Pharmaceuticals USA, Inc. — Lidocaine Hydrochloride, Preservative Free, Injection, 20 mg/1 mL (NDC 0143-9594-25) — FDA availability: Available — updated: 08/13/2026 - Hospira, Inc., a Pfizer Company — Lidocaine Hydrochloride In Plastic Container, Injection, 1,000 mg/50 mL (2%; 20 mg/mL) (NDC 0409-4277-02) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Lidocaine Hydrochloride In Plastic Container, Injection, 200 mg/20 mL (1%; 10 mg/mL) (NDC 0409-4276-01) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Lidocaine Hydrochloride In Plastic Container, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4275-01) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Lidocaine Hydrochloride In Plastic Container, Injection, 400 mg/20 mL (2%; 20 mg/mL) (NDC 0409-4277-01) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Lidocaine Hydrochloride In Plastic Container, Injection, 500 mg/50 mL (1%; 10 mg/mL) (NDC 0409-4276-02) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 100 mg/5mL (2%,20 mg/1 mL) Syringes (NDC 0409-1323-05) — FDA availability: Limited Availability — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 50 mg/5mL (1%, 10 mg/1 mL) Syringes (NDC 0409-9137-05) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Lidocaine Hydrochloride Preservative Free, Injection, 200 mg/2 mL (1%; 10 mg/mL) (NDC 0409-4713-32) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Lidocaine Hydrochloride Preservative Free, Injection, 200 mg/5 mL (4%; 40 mg/mL) (NDC 0409-4283-01) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Lidocaine Hydrochloride Preservative Free, Injection, 300 mg/20 mL (1.5%; 15 mg/mL) (NDC 0409-4776-01) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Lidocaine Hydrochloride Preservative Free, Injection, 50 mg/5 mL (1%; 10 mg/mL) (NDC 0409-4713-02) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Lidocaine Hydrochloride, Injection, 1%, USP (For Cardiac Use Only) 50 mg/5 mL (10 mg/mL) LifeShield™ ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4904-34)" — FDA availability: Not stated — updated: 11/07/2025 - Hospira, Inc., a Pfizer Company — Lidocaine Hydrochloride, Injection, 100 mg/5 mL (2%; 20 mg/mL) (NDC 0409-2066-05) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Lidocaine Hydrochloride, Injection, 100 mg/5mL (2%, 20 mg/1 mL) Syringes (NDC 0409-4903-34) — FDA availability: Unavailable — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Lidocaine Hydrochloride, Injection, 2%, USP (For Cardiac Use Only) 100 mg/5 mL (20 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4903-34)" — FDA availability: Not stated — updated: 11/07/2025 - Hospira, Inc., a Pfizer Company — Lidocaine Hydrochloride, Injection, 200 mg/10 mL (2%; 20 mg/mL) (NDC 0409-4282-02) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Lidocaine Hydrochloride, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4278-01) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Lidocaine Hydrochloride, Injection, 300 mg/30 mL (1%; 10 mg/mL) (NDC 0409-4279-02) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Lidocaine Hydrochloride, Injection, 40 mg/2 mL (2%; 20 mg/mL) (NDC 0409-4282-01) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Lidocaine Hydrochloride, Injection, 50 mg/5mL (1%,10 mg/1 mL) Syringes (NDC 0409-4904-34) — FDA availability: Unavailable — updated: 08/07/2026 - Huons Co., Ltd. (South Korea) — Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 73293-0001-2) — FDA availability: Unavailable — updated: 07/30/2026 - Spectra Medical Devices, LLC — Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 65282-1605-1) — FDA availability: Unavailable — updated: 05/15/2026 ## Sources and formats - [FDA openFDA source](https://api.fda.gov/drug/shortages.json) - [Canonical HTML](https://citefacts.com/shortages/lidocaine-hydrochloride-injection) - [JSON record](https://citefacts.com/shortages/lidocaine-hydrochloride-injection.json)